Feature | Richard R. Rogoski
Preliminary results of a multicenter study show that the use of tiny clips to repair the mitral valve may someday ...
July 09, 2008
News
July 10, 2008 - Datascope Corp. said today it exercised its option to acquire the Peripheral Vascular Stent business of ...
July 09, 2008
Feature | Nick Obradovich
The only safe assumption to make about today’s current gold standard imaging modality used to identify and evaluate atheromatous plaque in the peripheral arteries is that there is not one gold standard. To locate and evaluate these plaques that cause peripheral vascular disease (PVD), physicians have multiple tried-and-true imaging tests at their disposal.
July 09, 2008Sponsored Content
Feature
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
June 17, 2025News
July 10, 2008 - A novel blood pool magnetic resonance angiography (MRA) agent, Vasovist (gadofosveset trisodium), has ...
July 09, 2008
Technology
The Abiomed Inc. Impella 2.5 cardiac assist device was FDA cleared in 2008 for use for partial circulatory support for periods up to six hours. The intra-aortic balloon pump (IABP) also has 510(k) clearance and approximately 110,000 are used each year in the U.S.
July 08, 2008Technology
The FloTrac is reportedly the first minimally invasive hemodynamic monitoring device that connects to any existing arterial line and requires no manual calibration. The latest enhancement to the FloTrac software empowers clinicians with greater flexibility to trend and analyze the patient parameters in order to make better informed decisions, said the company.
July 08, 2008Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024News
July 9, 2008 – The Medical Imaging & Technology Alliance (MITA) today applauded the U.S. Congress for passing Medicare ...
July 08, 2008
Technology
The ACUSON SC2000 volume imaging ultrasound system acquires nonstitched, real-time full-volume 3D images of the heart in ...
July 08, 2008Technology
The Sorin Group said the FDA approved to market the CRT model of its OVATIO family, reportedly the smallest CRT defibrillator (CRT-D) available. The OVATIO CRT 6750 is shaped to offer ease of implantation and long-term patient comfort, and is designed to allow more flexibility in the management of cardiac resynchronization and antitachyarrhythmia therapy due to its Brady-Tachy Overlap (BTO).
July 08, 2008Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Technology
Recently introduced at the Heart Rhythm Society (HRS 2008) meeting, the new DigiTrak XT Holter recorder is reportedly equipped with powerful and innovative technology aimed at simplifying the patient and clinical user experience.
July 08, 2008News
July 9, 2008 - InnerSpace has added the V-Series line of heavy-duty cabinets, carts and workstations to its organized ...
July 08, 2008
Technology
Siemens' ACUSON SC2000 volume imaging ultrasound system acquires nonstitched, real-time full-volume 3D images of the heart in one single heart cycle. Called “Echo in a Heartbeat,” this new technology generates nonstitched full-volume imaging reportedly of the entire heart with 90 degree pyramids and in just one second.
July 08, 2008Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023Technology
Angiotech Pharmaceuticals Inc. received 510(k) clearance from the FDA to market its 5-Fluorouracil (5-FU) coated central venous catheter (CVC).
July 08, 2008News
July 9, 2008 - New research shows catheter cryoablation is comparably effective to radiofrequency catheter ablation for the treatment of atrial flutter (AFL) and may have some safety advantages over the use of radiofrequency.
July 08, 2008Technology
The FDA cleared Boston Scientific’s ALTRUA family of pacemakers, which enables the company to introduce its first Boston Scientific-branded pacemaker to treat bradycardia.
July 08, 2008